Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 301,322 shares at $45.11 ($13.6M) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Scheduled sale ($13.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.92 | 16,667 | $749K | 5.5% |
| 2 | $44.92 | 16,667 | $749K | 5.5% |
| 3 | $44.97 | 2,792 | $126K | 0.9% |
| 4 | $44.97 | 2,792 | $126K | 0.9% |
| 5 | $45.04 | 50,000 | $2.3M | 16.6% |
| 6 | $45.05 | 47,534 |
| $2.1M |
| 15.8% |
| 7 | $45.05 | 47,534 | $2.1M | 15.8% |
| 8 | $45.11 | 41,667 | $1.9M | 13.8% |
| 9 | $45.11 | 41,667 | $1.9M | 13.8% |
| 10 | $45.14 | 17,001 | $767K | 5.7% |
| 11 | $45.14 | 17,001 | $767K | 5.7% |
| Total | $45.06 avg | 301,322 | $13.6M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |
| HIMS | SELL | 2025-07-23 | $9.9M | — | Filing → |